mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
0.06 |
0.8 |